scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1084131682 |
P356 | DOI | 10.1038/SREP43777 |
P932 | PMC publication ID | 5333148 |
P698 | PubMed publication ID | 28252112 |
P50 | author | Dan J. Stein | Q5213742 |
Sabine Bahn | Q28469526 | ||
Anne Uhlmann | Q56987358 | ||
Man Chan | Q56989966 | ||
Dalila Pinto | Q38112120 | ||
P2093 | author name string | Michael S Breen | |
Sureyya Ozcan | |||
P2860 | cites work | The dopamine hypothesis of schizophrenia: version III--the final common pathway | Q22242827 |
The cerebellum and addiction: insights gained from neuroimaging research | Q26828743 | ||
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders | Q26864417 | ||
A review of the clinical pharmacology of methamphetamine | Q28244252 | ||
The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
Diffusion Tensor Imaging of the Brain | Q28972504 | ||
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data | Q29615647 | ||
The basis of anisotropic water diffusion in the nervous system - a technical review | Q29616528 | ||
Simultaneous inference in general parametric models | Q29619454 | ||
A revised version of the psychoticism scale | Q30051509 | ||
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments | Q30080030 | ||
White-matter abnormalities in brain during early abstinence from methamphetamine abuse | Q33643608 | ||
Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry | Q34010400 | ||
Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamine | Q34022333 | ||
Diffusion tensor imaging in schizophrenia | Q57403941 | ||
Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA | Q58114574 | ||
Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection | Q60181562 | ||
Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples | Q80720266 | ||
Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis | Q86829146 | ||
Towards a blood-based diagnostic panel for bipolar disorder | Q48073166 | ||
Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder. | Q48084166 | ||
Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis | Q48156818 | ||
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients | Q48339668 | ||
Decreased frontal white-matter integrity in abstinent methamphetamine abusers | Q48347308 | ||
Serum proteomics of methamphetamine addicts and up-regulation of complement factor H related to methamphetamine addiction | Q48417072 | ||
Virtual in vivo interactive dissection of white matter fasciculi in the human brain. | Q48426204 | ||
Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder | Q48557994 | ||
Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. | Q49017708 | ||
Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis. | Q51105028 | ||
Fiber tract-based atlas of human white matter anatomy | Q34279968 | ||
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset | Q34484906 | ||
Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs | Q34486911 | ||
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals | Q34492046 | ||
Apolipoproteins in the brain: implications for neurological and psychiatric disorders | Q34680878 | ||
The neurobiology of apolipoproteins in psychiatric disorders | Q34995089 | ||
Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project | Q35096541 | ||
Protein significance analysis in selected reaction monitoring (SRM) measurements | Q35878777 | ||
Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? | Q36049902 | ||
variancePartition: interpreting drivers of variation in complex gene expression studies. | Q36203417 | ||
Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder | Q36351715 | ||
Evidence for white matter abnormalities in schizophrenia | Q36460207 | ||
Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template | Q36782356 | ||
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment | Q36998471 | ||
Prevalence of psychotic symptoms in substance users: a comparison across substances | Q37346851 | ||
Serum proteomic profiling of major depressive disorder | Q37347574 | ||
Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report | Q37349915 | ||
Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome | Q37528958 | ||
The neurobiology of methamphetamine induced psychosis | Q38237633 | ||
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders | Q38244876 | ||
Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. | Q38399332 | ||
Synaptic vesicle dynamic changes in a model of fragile X. | Q38693916 | ||
Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discovery | Q38819329 | ||
White matter microstructure and impulsivity in methamphetamine dependence with and without a history of psychosis | Q38900777 | ||
Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts. | Q39139419 | ||
Psychosis post corona radiata and lentiform nucleus infarction | Q39757070 | ||
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia | Q40834916 | ||
Stress and lipoprotein metabolism: modulators and mechanisms | Q40865498 | ||
Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders | Q41651452 | ||
Microstructural Changes of Anterior Corona Radiata in Bipolar Depression | Q42103235 | ||
Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography | Q42285641 | ||
Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress | Q44078648 | ||
Functional magnetic resonance imaging of methamphetamine craving | Q46063734 | ||
A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins | Q46308632 | ||
Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan | Q46554056 | ||
(1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis | Q46732068 | ||
Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis | Q47593679 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diffusion tensor imaging | Q30088257 |
P304 | page(s) | 43777 | |
P577 | publication date | 2017-03-02 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis | |
P478 | volume | 7 |
Q92806896 | Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options | cites work | P2860 |
Search more.